Back

Elamipretide.

29 April 2017 (15:39 - 15:57)
Organised by:
Congress Presentation Part of: Novel drugs in acute heart failure: hurdles, hype and hope Acute heart failure (therapy) HFA Premium Access Heart Failure 2017 - 4th World Congress on Acute Heart Failure

About the speaker

Photo
Professor Hani Sabbah

Henry Ford Hospital, Detroit (United States of America)

4 More presentations in this session

Presentation thumbnail
Serelaxin.
Professor M. Metra (Milan, IT)
Slides Video
Presentation thumbnail
HNO Donors.
Professor J. Butler (Dallas, US)
Slides Video
Presentation thumbnail
Omecamtiv mecarbil
Professor J. Teerlink (San Francisco, US)
Slides Video
Presentation thumbnail
Vericiquat.
Professor B. Pieske (Rostock, DE)
Slides Video

Access the full session

Session thumbnail
Novel drugs in acute heart failure: hurdles, hype and hope

The Event

Event poster

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April 2017 15:39 CET
You may be interested in
thumbnail
Congress Presentation
Mitochondrial targeting by Elamipretide improves cardiac mitochondrial function without improving cardiovascular performance in HFpEF
23 April 2026
thumbnail
Congress Presentation
Managing dyslipidemia in the elderly: efficacy and safety of bempedoic acid in very high-risk patients
4 April 2025
thumbnail
Congress Presentation
Tafamidis treatment in patients with transthyretin amyloid cardiomyopathy
29 June 2021
thumbnail
Congress Presentation
Discovery and preclinical development of LY3473329, a potent small molecule inhibitor of lipoprotein(a) formation
27 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources